Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand

Am J Trop Med Hyg. 1992 Jul;47(1):108-11. doi: 10.4269/ajtmh.1992.47.108.

Abstract

Reports of deteriorating quinine efficacy prompted us to investigate the ability of quinine-tetracycline to clear parasites and fever from patients with multiple drug-resistant Plasmodium falciparum infections. Past and present treatment results were compared at two study sites along the Thai-Cambodian border. In northeastern Thailand, quinine-tetracycline cleared parasites more quickly in 1990 than in 1987 (mean 3.4 and 4.0 days, respectively; P = 0.006). In southeastern Thailand, there were no significant differences between 1990 (n = 26) and 1981-1983 (n = 42) in the time taken to clear either parasites (median 96 and 93 hr, respectively; P = 0.35) or fever (mean 74 and 66 hr, respectively; P = 0.30). In vitro drug sensitivity testing revealed a two-fold decrease in susceptibility to quinine between 1983 and 1990 in isolates from the southeastern Thai-Cambodian border (mean inhibitory concentration 166 ng/ml and 320 ng/ml, respectively; P less than 0.001). We conclude that oral quinine-tetracycline continues to reliably clear parasites and fever from falciparum malaria patients infected in eastern Thailand. Periodic re-evaluations are warranted, however, since the decrease in vitro susceptibility to quinine may be followed by an in vivo decay in the treatment response.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Animals
  • Drug Resistance
  • Drug Therapy, Combination
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Male
  • Military Personnel
  • Plasmodium falciparum / drug effects*
  • Prospective Studies
  • Quinine / pharmacology
  • Quinine / therapeutic use*
  • Tetracycline / pharmacology
  • Tetracycline / therapeutic use*
  • Thailand

Substances

  • Quinine
  • Tetracycline